• Publications
  • Access to hepatitis C treatment: How are phar...
Published on 24 Nov 2015

Access to hepatitis C treatment: How are pharma companies improving access to essential treatments?

The first systematic overview of the policies and practices put in place by pharmaceutical companies to address the accessibility of their hepatitis C treatments. The study analyses data submitted to the 2014 Access to Medicine Index.

Back to top |